Chongqing Xinyaosheng Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Chongqing Xinyaosheng Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ETBOBDE. The owner is based in Chongqing.

Room 3-3-3, Building 5, No. 101, Cuibai Road

Chunhui Road, Dadukou District

Chongqing 400000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ETBOBDE
ETBOBDE
Registered 2025

Trademark Classifications

Chongqing Xinyaosheng Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Chongqing Xinyaosheng Technology Co., Ltd. have?

Chongqing Xinyaosheng Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Chongqing Xinyaosheng Technology Co., Ltd. file in?

Chongqing Xinyaosheng Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Chongqing Xinyaosheng Technology Co., Ltd.'s most well-known trademarks?

Chongqing Xinyaosheng Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as ETBOBDE. These are among 1 currently registered trademark in the portfolio.

What is Chongqing Xinyaosheng Technology Co., Ltd.'s trademark registration success rate?

Chongqing Xinyaosheng Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.